Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02216409
Title Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Forty Seven, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford Cancer Institute Stanford California 94305 United States Details
University of Chicago Chicago Illinois 60637 United States Details
START Midwest Grand Rapids Michigan 49503 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
University of Oklahoma Oklahoma City Oklahoma 73104 United States Details
South Texas Accelerated Research Therapeutics San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field